I am a
Home I AM A Search Login

Papers of the Week

2020 May 01

J Oncol Pharm Pract

Dinutuximab in adult-onset chemotherapy refractory high-risk neuroblastoma.


Garrovillo K, Garrett J, Bollin K, Nasraty F, Sikand H
J Oncol Pharm Pract. 2020 May 01:1078155220918920.
PMID: 32356686.


Neuroblastoma is the most common extracranial solid tumor in pediatrics but is considerably uncommon in adults, with approximately 1 case per 10 million diagnosed per year and is associated with poor prognosis. There are no standard treatment protocols for adult-onset neuroblastomas and there are only a few published case reports on neuroblastoma in adults.